Actively Recruiting
Blood Biomarkers to Predict the Prognosis of a Stroke Patient Undergoing Mechanical Thrombectomy
Led by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla · Updated on 2024-06-21
400
Participants Needed
2
Research Sites
64 weeks
Total Duration
On this page
Sponsors
F
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Lead Sponsor
H
Hospitales Universitarios Virgen del Rocío
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate the accuracy of a panel of blood biomarkers and clinical variables in predicting the prognosis of stroke patients treated by mechanical thrombectomy, specifically to predict futile recanalization and mortality.
CONDITIONS
Official Title
Blood Biomarkers to Predict the Prognosis of a Stroke Patient Undergoing Mechanical Thrombectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients > 18 years old.
- Patient in whom a mechanical thrombectomy is performed.
You will not qualify if you...
- Impossibility of getting a blood sample.
- Impossibility of performing the test (Invalid results)
- Refusal to provide the informed consent by the patient/relative.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hospital Universitario Reina Sofía
Córdoba, Spain
Actively Recruiting
2
Hospital Universitario Virgen Rocío
Seville, Spain
Actively Recruiting
Research Team
R
Rosa M Delgado
CONTACT
C
Carmen De Jesús Gil
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here